Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 360 | N/A | N/A | N/A | 690 |
| Receivables | 4,160 | N/A | N/A | N/A | 4,080 |
| Inventories | 2,810 | N/A | N/A | N/A | 1,970 |
| Other current assets | 340 | 0 | 0 | 0 | 10 |
| TOTAL | $7,670 | $N/A | $N/A | $N/A | $6,750 |
| Non-Current Assets | |||||
| Investments And Advances | 320 | 0 | 0 | 0 | 280 |
| Other Non-Current Assets | 3,892 | 0 | 0 | 0 | 3,710 |
| TOTAL | $4,212 | $N/A | $N/A | $N/A | $3,990 |
| Total Assets | $14,090 | $N/A | $N/A | $N/A | $12,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 360 | N/A | N/A | N/A | 160 |
| Accounts payable and accrued liabilities | 2,550 | 0 | 0 | 0 | 2,670 |
| Other current liabilities | 1,110 | N/A | N/A | N/A | 940 |
| TOTAL | $5,050 | $N/A | $N/A | $N/A | $4,550 |
| Non-Current Liabilities | |||||
| Long Term Debt | 620 | N/A | N/A | N/A | 170 |
| Other Non-Current Liabilities | 1,090 | 0 | 0 | 0 | 850 |
| TOTAL | $1,710 | $N/A | $N/A | $N/A | $1,020 |
| Total Liabilities | $6,770 | $N/A | $N/A | $N/A | $5,580 |
| Shareholders' Equity | |||||
| Common Shares | 100 | N/A | N/A | N/A | 100 |
| Retained earnings | -20,770 | N/A | N/A | N/A | -20,980 |
| Other shareholders' equity | -120 | 0 | 0 | 0 | -370 |
| TOTAL | $7,310 | $N/A | $N/A | $N/A | $6,790 |
| Total Liabilities And Equity | $14,080 | $0 | $0 | $0 | $12,370 |